111 Capital’s Chemed CHE Stock Holding History

111 Capital’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-468	Closed	-$288K	–	542
2025 Q1	$288K	Buy	+468	New	+$266K	0.06%	333

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

111 Capital's CHE Position: Q2 2025 in Review

111 Capital sold out of Chemed (CHE) in Q2 2025, closing a stake of 468 shares — an estimated $288K sold.

111 Capital first reported a position in CHE in Q1 2025 and held it in 1 quarter. The position peaked at $288K in Q1 2025. 537 funds tracked by Wall St. Rank hold CHE as of Q2 2025.

111 Capital reported no remaining Chemed position as of Q2 2025 after selling out during the quarter.
111 Capital sold 468 Chemed shares in Q2 2025, an estimated $288K.
111 Capital first reported a position in Chemed in Q1 2025 and held it in 1 quarter.
111 Capital's Chemed position peaked at $288K in Q1 2025.
537 funds tracked by Wall St. Rank held Chemed as of Q2 2025.

Based on 111 Capital's 13F filing for Q2 2025, filed 21 Jul 2025.